Onkologie. 2013:7(4):190-196

Patients with colorectal cancer and their subsequent and previous neoplasms

Edvard Geryk1, Petr Dítě2, Radim Štampach3, Teodor Horváth4, Jiří Kozel3
1 Oddělení vědy a výzkumu, Fakultní nemocnice Brno
2 II. interní klinika LF MU, Fakultní nemocnice Brno
3 Geografický ústav, Masarykova univerzita, PřF, Brno
4 Chirurgická klinika FN Brno, Lékařská fakulta MU, Brno

Among the total of 99,378 new colorectal cancers (CRCs) in males and 78,977 in females, based on the Czech Cancer Registry in 1976–2005, there

were 14,860 (15 %) CRCs in males and 11,142 (14.1 %) in females associated with the other malignant neoplasms (MNs). The primary 6,504 CRCs

in males were followed by 7,406 subsequent MNs, the primary 4,342 CRCs in females by 4,798 subsequent MNs. On the contrary before the

subsequent 8,356 CRCs in males were registered 10,152 primary MNs, 6,800 CRCs in females 7,829 MNs. The number of multiple CRCs increased

from 141 in 1976 to 1,534 in 2005. In 1996–2005 the primary CRCs reached 57 % of early, 30 % advanced and 13 % unknown clinical stages, respectively

the subsequent CRCs of 43.5 %, 34 % and 22.5 %. The occurrence of all multiple CRCs were highest in the age group of 50–69 years

in males, and of 70–79 years in females. The average interval between primary CRCs and subsequent MNs was 5.1 years in males and 5.4 years

in females. The most frequent MNs following primary CRCs were cancers of the gastrointestinal tract, skin, genital organs and urinary tract.

Nearly half of synchronous MNs after primary CRCs were cancers of the gastrointestinal tract. There were 19 % cases diagnosed at advanced

stages from the total 12,204 subsequent MNs, one half of those in patients with gastrointestinal cancers. More than one third of primary MNs

preceded by 17,981 subsequent CRCs were cancers of the skin. Among 1,715 (26.4 %) males and 1,206 (27.8 %) females survived up to 2007 with

primary CRCs, there were higher early stages than with subsequent CRSc; on the contrary among 6,646 (79.5 %) males and 5,291 (77.8 %) females,

died up to 2007 with subsequent CRCs, were higher advanced stages than with primary CRCs. By the above mentioned data is estimated that

among a total of 8,265 CRCs registered in 2010 were nearly 1,700 (21 %) multiple CRCs, i.e. 260 primary and 1,440 subsequent cases. Every

fifth CRC was associated with the occurrence of the other MNs. Although it is difficult to estimate the number of multiple cases among 53,340

survivors with CRCs in 2010, their ongoing trend will increase the burden of diagnostic and therapeutic capabilities.

Keywords: multiple colorectal cancer, primary and subsequent neoplasms, time and space distribution, clinical stages

Published: October 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Geryk E, Dítě P, Štampach R, Horváth T, Kozel J. Patients with colorectal cancer and their subsequent and previous neoplasms. Onkologie. 2013;7(4):190-196.
Download citation

References

  1. Hicks RJ, Ell PJ, Hirsch BR, et al. Delivering affordable cancer care in high-income countries. Lancet Oncol 2011; 12: 933-980. Go to original source... Go to PubMed...
  2. Simoens S, Dooms M. How much is the life of a cancer patient worth? A pharmaco-economic perspective. J Clin Pharm and Therap 2011; 36: 249-256. Go to original source... Go to PubMed...
  3. Brown ML, Riley GF, Schussler M, et al. Estimating health care costs related to cancer treatment from SEER-medicare data. Med Care 2002; 40: IV 104-IV 117. Go to original source... Go to PubMed...
  4. Geryk E, Horváth T, Konečný M. Očekávaná zátěž nádory jícnu, žaludku a kolorekta ve světě. Vnitř. Lék. 2011; 57(12): 1006-1011.
  5. IARC/WHO. Globocan 2008. Lyon: IARC, http://globocan.iarc.fr/. UP DATED TO OCTOBER 2013.
  6. Mysliwiec P, Cronin KA, Schatzkin A. New malignancies following cancer of the colon, rectum, and anus. In: Curtis RE. et al. New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000. National Cancer Institute, Bethesda, MD, 2006: 502, http://seer.canc.gov.
  7. Neugut AI, Murray TI, Lee WC, et al. The association of breast cancer and colorectal cancer in men. An analysis of SEER Program data. Cancer 1991; 68(9): 2069-2073. Go to original source... Go to PubMed...
  8. Shureiqi I, Cooksley CD, Morris J, et al. Effect of age on risk of second primary colorectal cancer. J Natl Cancer Inst. 2001; 93(16): 1264-1266. Go to original source... Go to PubMed...
  9. Evans HS, Moller H, Robinson D, et al. The risk of subsequent primary cancers after colorectal cancer in southeast England. Gut 2002; 50(5): 647-652. Go to original source... Go to PubMed...
  10. McCredie M, Macfarlane GJ, Bell J, et al. Second primary cancers after cancers of the colon and rectum in New South Wales, Australia, 1972-1991. Cancer Epidemiol Biomarkers Prev. 1997; 3: 155-160. Go to original source...
  11. Levi F, Randimbison L, Te VC, et al. Multiple primary cancers in the Vaud Cancer Registry, Switzerland, 1974-89. Br J Cancer 1993; 67(2): 391-395. Go to original source... Go to PubMed...
  12. Lynge E, Jensen OM, Carstensen B. 1985. Second cancer following cancer of the digestive system in Denmark, 1943-80. Natl Cancer Inst Monogr 1985; 68: 277-308. Go to PubMed...
  13. Brinton LA, Lacey JV, Sherman ME. Epidemiology of gynecologic cancers. In Hoskins WJ,, et al. Principles and Practice of Gynecologic Oncology, 4th ed. Philadelphia, Lippincott Williams & Wilkins, 2004: 3-32. Go to original source...
  14. Boice JD Jr, Engholm G, Kleinerman RA, et al. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res. 1988; 116(1): 3-55. Go to original source...
  15. Travis LB, Curtis RE, Boice JD Jr, et al. 1996. Second malignant neoplasms among long-term survivors of ovarian cancer. Cancer Res. 1996; 56(7): 1564-1570.
  16. Rabkin CS, Biggar RJ, Melbye M, et al. Second primary cancers following anal and cervical carcinoma: evidence of shared etiologic factors. Am J Epidemiol 1992; 136(1): 54-58. Go to original source... Go to PubMed...
  17. Frisch M, Olsen JH, Melbye M. Malignancies that occur before and after anal cancer: clues to their etiology. Am J Epidemiol 1994; 140(1): 12-19. Go to original source... Go to PubMed...
  18. Ferenczy A, Coutlee F, Franco E, et al. Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments. CMAJ 2003; 169(5): 431-434. Go to PubMed...
  19. Palefsky JM, Holly EA. Chapter 3: Immunosuppression and co-infection with HIV. J Natl Cancer Inst Monogr 2004; 31: 41-46. Go to original source...
  20. Chin-Hong PV. Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus. Clin Infect Dis 2002; 35(9): 1127-1134. Go to original source... Go to PubMed...
  21. Frisch M, et al. Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res 1999; 59(3): 753-757.
  22. Trimble CL, Hildesheim A, Brinton LA, et al. Heterogeneous etiology of squamous carcinoma of the vulva. Obstet Gynecol 1996; 87(1): 59-64. Go to original source... Go to PubMed...
  23. Frisch M, Biggar RJ. Aetiological parallel between tonsillar and anogenital squamous-cell carcinomas. Lancet 1999; 354(9188): 1442-1443. Go to original source... Go to PubMed...
  24. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subret of head and neck cancers. J Natl Cancer Inst 2000; 92, 9: 709-720. Go to original source... Go to PubMed...
  25. Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993; 71(3): 677-685. Go to original source... Go to PubMed...
  26. Burt RW. 2000. Colon cancer screening. Gastroenterology 2000; 119(3): 837-853. Go to original source... Go to PubMed...
  27. Ekbom A, Helmick C, Zack M, et al. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 1990; 336(8711): 357-359. Go to original source... Go to PubMed...
  28. Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990; 323(18): 1228-1233. Go to original source... Go to PubMed...
  29. Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol Clin North Am. 2002; 31(4): 925-943. Go to original source... Go to PubMed...
  30. Corrao G, Bagnardi V, Zambon A, et al. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med. 2004; 38(5): 613-619. Go to original source... Go to PubMed...
  31. Wei EK, Giovannucci E, Wu K, et al. Comparison of risk factors for colon and rectal cancer. Int J Cancer 2004; 108(3): 433-442. Go to original source... Go to PubMed...
  32. Dítě P, Geryk E. Trends of primary and subsequent cancers of the gastrointestinal tract in the Czech population, 1976-2005. Digestive Dis. 2010; 28: 657-669. Go to original source... Go to PubMed...
  33. Geryk E, Dítě P, Kozel J, kol. Nádorové multiplicity u české populace. Čas Lék Čes 2010; 149(4): 178-183.
  34. UZIS: Novotvary ČR 2010. Zdravotnická statistika, Praha: UZIS ČR, 2013: 264, ISBN 978-80-7472-034-5, www.uzis.cz.
  35. Konečný, M, Geryk E, Kubíček P, kol. Prevalence nádorů v České republice, 1989-2005-2015. Brno: PřF MU, 2008: 69, ISBN 978-80-903255-2-4.
  36. Geryk E, Dítě P, Trna J, kol. Klinická stadia u nemocných s vícečetnými novotvary. Onkologie, 2010; 4(6): 357-361.
  37. Geryk E, Dítě P, Sedláková L, kol. Trend vícečetných nemelanomových nádorů kůže z pohledu jejich epidemiologie. Dermatologie pro praxi, 2010; 4(1): 5-9.
  38. Horváth T, Geryk E, Kozel J, kol. Rakovina plic ve vícečetných malignitách. Stud Pneumol Phthiseol, 2013; 73(3): 109-116.
  39. Sullivan S, Peppercorn J, Sikora K, et al. Delivering affordable cancer care in high-income countries. Lancet Oncol 2011; 12: 933-980. Go to original source... Go to PubMed...
  40. Meropol NJ, Schulman KA. Cost of cancer care: issues and implications. J Clin Oncol 2007; 25: 180-186. Go to original source... Go to PubMed...
  41. Mariotto A, Yabroff RK, Feuer EJ, et al. Projecting the number of patients with colorectal carcinoma by phases of care in the US: 2000-2020. Cancer Causes Control 2006; 17: 1215-1226. Go to original source... Go to PubMed...
  42. Geryk E, Koška P, Horváth T, kol. Nádory, zdraví a ekonomika - součást Pandořiny skříňky? Onkologie 2013; 7(1): 40-46.
  43. VZP. Ročenka Všeobecné zdravotní pojišťovny České republiky za rok 2010. Praha: B.I.G. Prague, 2011: 68, www.vzp.cz.
  44. Francisci S, Guzzinati S, Mezzetti M, et al. Cost profiles of colorectal cancer patients in Italy based on individual patterns of care. BMC Cancer 2013; 13: 329. Go to original source... Go to PubMed...
  45. Rushton G, Peleg I, Banerjee A, et al. Analyzing geographic patterns of disease incidence: Rates of late-stage colorectal cancer in Iowa. J Med Systems, 2004; 28(3): 223-236. Go to original source... Go to PubMed...
  46. Cromley EK, McLafferty SL. GIS and public health. N.Y.: Guilford Press, 2002: 340, SBN 1-57230-707-2.
  47. Yagoub MM. GIS application for health. Int J Geoinformatics, 2011; 7(1): 21-28.
  48. Štampach R, Konečný M, Kubíček P, et al. Dynamic cartographic methods for visualization of health statistics. In: Partner G, Ortag F. Cartography in Central and Eastern Europe. Berlin-Heidelberg: Springer-Verlag 2010: 431-442. Go to original source...
  49. Geryk E, Štampach R, Dítě P, kol. Clinical stages in patients with primary and subsequent cancers based on the Czech Cancer Registry 1976-2005. ISRN Oncology, vol. 2013, 2013: 1-10. http://www.hindawi.com/isrn/oncology/2013/829486/. Go to original source... Go to PubMed...
  50. MZ. Systém podpory prevence vybraných nádorových onemocnění v ČR - Screeningové programy. Projekt MZ ČR, 12. 6. 2013, http://www.mzcr.cz/dokumenty/rizeni.
  51. Giannakouris K. Regional population projections EUROPOP2008: Most EU regions face older population profile in 2030. In Eurosatat: Statistics in Focus. Luxembourg: European Commission, 2010.
  52. Sullivan R, Peppercorn P, Sikora K, et al. Delivering affordable cancer care in high-income countries. Lancet Oncol 2011; 12(10): 933-980. Go to original source... Go to PubMed...
  53. Fishman J, Ten Have T, Casarett D. Cancer and the media: how does the news report on treatment and outcomes? Arch Intern Med 2010; 170(6): 515-518. Go to original source... Go to PubMed...
  54. Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage 2006; 31(1): 58-69. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.